Article

Phase II randomized controlled trial to evaluate the efficacy and safety of HeberFERON versus Heberon alpha R in symptomatic or asymptomatic patients infected with the SARS-CoV-2 (Study ESPERANZA/HOPE).

2020-12-30

Abstract excerpt

<h4>Background: </h4> As the outbreak of COVID-19 has accelerated, an urgent need for finding strategies to combat the virus is growing. Results from in vitro studies suggest that a combination of IFN type I and Type II may be effective against SARS-CoV. The aim of this study is to investigate the efficacy of treatment with a recombinant IFN alpha 2b and gamma, provided with standard protocol (Kaletra (lopinavir-r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b1f9fa05-0822-550f-84f1-896c54252518
DOI: 10.21203/rs.3.rs-28958/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Phase II randomized controlled trial to evaluate the efficacy and safety of HeberFERON versus Heberon alpha R in symptomatic or asymptomatic patients infected with the SARS-CoV-2 (Study ESPERANZA/HOPE).DOI 10.21203/rs.3.rs-28958/v2Read

Effect of combination of interferon alpha-2b and interferon-gamma or interferon alpha-2b alone for elimination of SARS-CoV-2 viral RNA. Preliminary results of a randomized controlled clinical trialSemantic proximity Read

Therapeutic effectiveness of interferon-alpha 2b against COVID-19: the Cuban experienceSemantic proximity Read

Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study)Semantic proximity Read

Safety and pharmacodynamics of intranasal administration of recombinant human interferon alfa-2b as a potential prophylactic for SARS-CoV-2 infection in an at-risk group: a phase I-II clinical trial, open, uncontrolled, in a single-arm (OLIVO Study)Semantic proximity Read

Remdesivir-Nirmatrelvir Combination: In Vitro Activity and a Case ReportSemantic proximity Read

Favipiravir and/or Nitazoxanide: a randomized, double-blind, 2x2 design, placebo-controlled trial of early therapy in COVID-19 (FANTAZE).Semantic proximity Read

A Phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)Semantic proximity Read

Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.Semantic proximity Read

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trialSemantic proximity Read

Hydroxychloroquine Alone or in Combination with Cobicistat-Boosted Darunavir for Treatment of Mild COVID-19: A Cluster-Randomized Clinical TrialSemantic proximity Read

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variantsSemantic proximity Read